Publications and reports
Below is a list of publications that use data held by the Cancer Institute NSW.
This includes:
- NSW Cancer Registry
- NSW Clinical Cancer Registry (2008–2012)
- BreastScreen NSW
- NSW Pap Test Register
- Cancer Institute Tobacco Tracking Survey
Published date 10 January 2021
Even in the most extreme scenarios, assuming that 25% of cases were initially missed, including DCI cases underestimated 5-year survival by no more than three percentage points.
Published date 24 December 2020
There was variation in the use of palliative radiation therapy fractionation for brain metastases in NSW.
Published date 12 December 2020
Knowledge of late treatment-related effects can guide surveillance of survivors and treatment modification, without compromising the high rates of survival from childhood cancers.
Published date 09 December 2020
Differences in cancer registration practices were only able to partly explain international differences in cancer survival.
Published date 01 December 2020
The strongest and most consistent predictor of earlier stage at diagnosis was BreastScreen NSW participation.
Published date 01 December 2020
Source:
BMC Med. 2020 Dec 1;18(1):372
Physical disability, distress and reduced quality of life are common after cancer and vary according to cancer type.
Published date 18 November 2020
Single fraction radiation therapy is underused for the treatment of bone metastases in NSW.
Published date 16 November 2020
The incidence of hepatic cancer in children appears to have increased over the last 30 years in Australia and North America. Previously observed survival gaps between these countries were no longer apparent.
Published date 04 November 2020
The increasing use of CT scanning, improvements in pathological assessment of the appendix, and the growing aging population may have contributed in part to the apparent rise in the incidence of appendiceal neoplasms.
Published date 14 October 2020
In all countries, increasing age was associated with lower net survival, but older patients diagnosed with localised (and in some countries regional) stage colon cancer who survived 6 months after diagnosis experienced the same survival as their younger counterparts.
